Vivos Therapeutics, Inc.
VVOS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716166
No open-market purchases or sales by Vivos Therapeutics, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $242.7K in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Vivos Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 28 | 18 | −10 |
| SharesConverted for a 1-for-25 split | 179.0K | 257.0K | +78.0K (+43.6%) |
| Value | $860.6K | $3.12M | +$2.26M (+262.4%) |
New holders (4)
Institutions that held Vivos Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 57,000 | $709.1K | 0.02% |
| Schonfeld Strategic Advisors LLC | 50,100 | $623.2K | 0.01% |
| Tower Research Capital LLC (TRC) | 1,718 | $21.4K | 0.00% |
| Newbridge Financial Services Group, Inc. | 1,295 | $16.1K | 0.01% |
Sold out (14)
Institutions that held Vivos Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Geode Capital Management, LLC | 201,941 | $38.8K |
| HRT Financial LP | 87,697 | $16.0K |
| Wealth Enhancement Advisory Services, LLC | 53,334 | $10.2K |
| State Street Corp | 45,650 | $8.77K |
| Apexium Financial, LP | 40,667 | $7.81K |
| LPL Financial LLC | 35,484 | $6.82K |
| Northern Trust Corp | 29,655 | $5.70K |
| HighTower Advisors, LLC | 18,653 | $4.00K |
| Perkins Capital Management Inc | 15,000 | $3.00K |
| Lincoln National Corp | 14,817 | $2.85K |
| UBS Group AG | 9,257 | $1.78K |
| Qube Research & Technologies Ltd | 200 | $38 |
| JPMorgan Chase & Co | 26 | $5 |
| Simplex Trading, LLC | 167 | $0 |